Ross
Well-known member
MedWatch - The FDA Safety Information and Adverse Event Reporting Program
The FDA warned consumers not to purchase or to consume Actra-Rx or Yilishen,
two products promoted and offered for sale on Web sites as "dietary
supplements" for treating erectile dysfunction and enhancing sexual
performance for men. FDA testing of Actra-Rx found that the product
contained undeclared prescription-strength sildenafil. An interaction
between sildenafil and certain prescription drugs containing nitrates (such
as nitroglycerin) or nitrates found in illicit substances (such as amyl
nitrate) may cause a significant lowering of blood pressure to an unsafe
level. Consumers who have taken Actra-Rx or Yilishen should stop taking it
and consult with their health care providers regarding erectile dysfunction
treatment.
Read the MedWatch 2004 safety summary, including link to FDA Talk Paper:
http://www.fda.gov/medwatch/SAFETY/2004/safety04.htm#ActraRx
--------
Thank you for using MedWatch as a trusted source for timely safety information on drugs and other medical products regulated by the U.S. Food and Drug Administration. If you find this e-mail notification helpful, please consider telling colleagues and friends about MedWatch. They can learn more about us and subscribe/unsubscribe to the e-list at the MedWatch homepage, http://www.fda.gov/medwatch or by going directly to http://list.nih.gov/cgi-bin/wa?SUBED1=medwatch&A=1
This is an automated message delivery system -- replying to this message will not reach MedWatch staff. If you have comments or questions about MedWatch or this e-mail, please contact us through our comments & feedback web page, http://www.fda.gov/medwatch/feedback.htm
The FDA warned consumers not to purchase or to consume Actra-Rx or Yilishen,
two products promoted and offered for sale on Web sites as "dietary
supplements" for treating erectile dysfunction and enhancing sexual
performance for men. FDA testing of Actra-Rx found that the product
contained undeclared prescription-strength sildenafil. An interaction
between sildenafil and certain prescription drugs containing nitrates (such
as nitroglycerin) or nitrates found in illicit substances (such as amyl
nitrate) may cause a significant lowering of blood pressure to an unsafe
level. Consumers who have taken Actra-Rx or Yilishen should stop taking it
and consult with their health care providers regarding erectile dysfunction
treatment.
Read the MedWatch 2004 safety summary, including link to FDA Talk Paper:
http://www.fda.gov/medwatch/SAFETY/2004/safety04.htm#ActraRx
--------
Thank you for using MedWatch as a trusted source for timely safety information on drugs and other medical products regulated by the U.S. Food and Drug Administration. If you find this e-mail notification helpful, please consider telling colleagues and friends about MedWatch. They can learn more about us and subscribe/unsubscribe to the e-list at the MedWatch homepage, http://www.fda.gov/medwatch or by going directly to http://list.nih.gov/cgi-bin/wa?SUBED1=medwatch&A=1
This is an automated message delivery system -- replying to this message will not reach MedWatch staff. If you have comments or questions about MedWatch or this e-mail, please contact us through our comments & feedback web page, http://www.fda.gov/medwatch/feedback.htm
I'm sure there are a few stud muffins in here that won't admit the problem, but may have run across these products on the web. This is just a fair warning. 
